Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies:PROmics

Calvert, Melanie (Principal Investigator)
Newsome, Philip (Co-Investigator)
Kyte, Derek (Co-Investigator)
Harding, Rosie (Co-Investigator)
Rowe, Anna (Co-Investigator)

2 Article
1 Comment/debate
1 Review article

4 results

2023
Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial
McMullan, C., Retzer, A., Hughes, S., Aiyegbusi, O. L., Bathurst, C., Boyd, A., Coleman, J., Davies, E. H., Denniston, A., Dunster, H., Frost, C., Harding, R., Hunn, A., Kyte, D., Malpass, R., McNamara, G., Mitchell, S. A., Mittal, S., Newsome, P., Price, G., & 5 othersRowe, A., van Reil, W., Walker, A., Wilson, R. & Calvert, M., 9 Oct 2023, In: Journal of Patient-Reported Outcomes. 7, 1, 13 p., 98.
Research output: Contribution to journal › Article › peer-review

Open Access
File
39 Downloads (Pure)
Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review
Taylor, S., Law, K., Coomber-Moore, J., Davies, M., Thistlewaite, F., Calvert, M., Aiyegbusi, O. & Yorke, J., 30 Sept 2023, In: Systematic Reviews. 12, 1, 24 p., 183.
Research output: Contribution to journal › Review article › peer-review

Open Access
File
26 Downloads (Pure)
2022
Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study
Hughes, S., McMullan, C., Rowe, A., Retzer, A., Malpass, R., Bathurst, C., Davies, E. H., Frost, C., McNamara, G., Harding, R., Price, G., Wilson, R., Walker, A., Newsome, P. & Calvert, M., 6 Sept 2022, In: BMJ open. 12, 9, 10 p., e063199.
Research output: Contribution to journal › Article › peer-review

Open Access
File
35 Downloads (Pure)
The value of patient-reported outcomes in early phase clinical trials
Retzer, A., Aiyegbusi, O. L., Rowe, A., Newsome, P., Douglas-Pugh, J., Khan, S., Mittal, S., Wilson, R., O'Connor, D., Campbell, L., Mitchell, S. A. & Calvert, M., 17 Jan 2022, In: Nature Medicine. 28, 1, p. 18–20 3 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
File

97 Downloads (Pure)

Patient-reported outcomes assessment to support accelerated access to advanced cell and gene therapies:PROmics

Research output

Search results

Development and usability testing of an electronic patient-reported outcome (ePRO) solution for patients with inflammatory diseases in an Advanced Therapy Medicinal Product (ATMP) basket trial

Patient-reported outcome (PRO) instruments used in patients undergoing adoptive cell therapy (ACT) for the treatment of cancer: a systematic review

Feasibility of a new electronic patient-reported outcome (ePRO) system for an advanced therapy clinical trial in immune-mediated inflammatory disease (PROmics): protocol for a qualitative feasibility study

The value of patient-reported outcomes in early phase clinical trials